Logos Global Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Logos Global Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-800,000	Closed	-$23M	–	59
2024 Q3	$23M	Buy	+800,000	New	+$21.8M	2.49%	15
2023 Q3	–	Sell	-250,000	Closed	-$10.2M	–	65
2023 Q2	$10.2M	Sell	250,000 -100,000	-29%	-$4.08M	1.38%	23
2023 Q1	$13.5M	Buy	+350,000	New	+$14.4M	1.94%	22

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Logos Global Management's LKFT Position: Q4 2024 in Review

Logos Global Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2024, closing a stake of 800,000 shares — an estimated $23M sold.

Logos Global Management first reported a position in LKFT in Q1 2023 and held it in 3 quarters. The position peaked at $23M in Q3 2024. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.

Logos Global Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Logos Global Management sold 800,000 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2024, an estimated $23M.
Logos Global Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and held it in 3 quarters.
Logos Global Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $23M in Q3 2024.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.

Based on Logos Global Management's 13F filing for Q4 2024, filed 14 Feb 2025.